| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.57 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |